Xenopus nuclear factor 7 (xnt7) is a maternal gene product that functions in the determination of the dorsal-ventral body axis. We have cloned two xnf7 cDNAs, x&7-0 and xnf7-B, that have a different temporal pattern of expression. The cDNAs differ by 39 amino acid residues scattered throughout the molecule. Most of the changes were conservative in nature. Using gene specific probes we found that xnfrl-0 transcripts were abundant in oocytes and decreased until the neurula stage, after which they increased in abundance. Xnff -B transcripts were in low abundance in oocytes and were expressed at high levels at the neurula stage and in adult brain. Both xnf7-0 and xnf7-B transcripts at the neurula stage were localized in the dorsal region of the embryo, including the neural folds and somites. Xnt7 was not expressed in ventralized embryos that lacked dorsal structures, thereby substantiating its dorsal localization in the embryo. The promoter region of the xnf7-0 gene does not possess a TATA box but does contain E2F, USE Spl-like and API binding sites within the first 421 bp from the transcription initiation site. A 62 bp fragment of the xnt7-0 promoter containing the Spl-like and E2F sites can direct proper spatial expression of a transgene in embryos.
Introduction
An important question in developmental biology concerns the mechanisms involved in the establishment of the embryonic axis. The use of genetic approaches in Drosophila and molecular and embryological approaches in Xenopus laevis have enormously increased our understanding of the genetic and molecular basis underlying this process (Sive, 1993; Dawid, 1994; Slack, 1994) .
In addition to the involvement of several wellcharacterized growth factors and transcription factors in embryonic patterning, recent evidence indicates that Xenopus nuclear factor 7 (xnf7) also functions in the dorsal-ventral axial patterning (Shou et al., 1995, submitted) . Xnfl is a member of a novel family of zinc finger proteins, the B-box family, consisting mainly of transcription factors and protooncogenes Reddy et al., 1992; Freemont, 1993) . It is a maternal gene product that is retained in the cytoplasm during early embryogenesis until the mid-blastula transition (MBT) when * Corresponding author. it reenters all nuclei (Dreyer et al., 1983; Miller et al., 1989 Miller et al., , 1991 Li et al., 1994a) . During early embryogenesis it is likely that the xnf7 protein functions as a transcription factor regulating the expression of genes that are involved in dorsal-ventral patterning following its entry into the nucleus at the MBT.
The xnf7 gene is reexpressed during embryogenesis at the gastrula-neurula stage of development ; however, preliminary evidence indicates that its zygotic pattern of expression is limited to the central nervous system (CNS) and other dorsal structures. Indeed, analysis of the protein patterns in young larvae show that the xnf;l protein appears predominantly in the nuclei of the CNS (Dreyer et al., 1983) .
In this study we have discovered that in addition to the xnf7 cDNA previously described (called the brain clone xnf/-B) there is a second cDNA, xnf7-0 (xnf7 oocyte cDNA). These cDNAs differ by 39 amino acid changes scattered throughout the cDNA. The conservative nature of these changes suggests that most of these do not alter protein function; however, a ser-gly change in the B-box zinc-binding domain of the oocyte form could affect the function of this domain. Xnf7-0 is expressed during oogenesis and throughout all stages of early development from fertilization through tadpole stages. Xnff-B, on the other hand, is expressed at very low levels in oocytes andis predominantly expressed from gastrulation onward and in the adult brain. The expression of both xnfl-0 and xnfl-B is limited primarily to the CNS and dorsal axial structures during later stages of embryogenesis.
We cloned the oocyte type genomic sequence and performed a preliminary analysis of the elements involved in regulating its spatial and temporal patterns of expression. We showed that a 62 bp of the xnf7-0 promoter containing Spl-like and E2F sites can direct proper spatial expression of a transgene in embryos.
Results

The oocyte (Xnf-0) and brain (xrg7-B) cDNAs are likely encoded by two genes
We previously reported the cloning of a cDNA for xnf7 isolated from a Xenopus laevis brain library . Xnf7 belongs to a family of proteins that consists of 10 members most of which possess a tripartite motif containing the RING, the B-box zinc fingers and a coiled coil motif (Fig. 1) . The core group: xnt7 , rfp (Takahashi et al., 1988) , RPT-1 (Patarca et al., 1988) , PwA33 (Bellini et al., 1993) and SS-A-Ro (Chan et al., 1991) all possess the simple tripartite structure. PML (Goddard et al., 1991; Kakizuki et al., 1991; Kastner et al., 1991; DeThe et al., 1991) ; efp (Inoue et al., 1993) and T-18 (Miki et al., 1991) also have an additional B-box domain (B2), while ATDC (Leonhardt et al., 1994) and CA125 (Campbell et al., 1994) only possess the Bbox and coiled-coil domain. Also shown is the recently cloned breast cancer gene, BRCAl (Miki et al, 1994) which is a member of the RING finger family that possesses only the RING finger domain. We cannot identify any of these genes as direct homologues of xnf7.
Based on the complex Southern blot pattern of Xenopus genomic DNA we suspected that there were several copies of xnff in the genome and that there were other xn~ cDNAs (data not shown). Using a nucleic acid probe from the coding region of the xnt7 cDNA we (Freemont, 1993) , B-box (Reddy et al., 1992) and the coiled-coil domain within family members. The numbers in brackets represent distances between the domains. The core group consist of xnfl . Rpt-1 (Patarca et al., 1988) . SS-A-R0 (Chan et al., 1991) . Rfp (Takahashi et al., 1988) ; and PwA33 (Bellini et al., 1993) . The other members possess variations from the basic structure including duplications of the B-box, e.g. PML (Goddard et al., 1991; Kakizuki et al., 1991; deThe et al., 1991) ; T18 (Miki et al., 1991); efp (moue et al., 1993) or the absence of the RING finger domain, e.g. ATDC (Leonhardt et al., 1994) ; CA125 (Campbell et al., 1994) . Also shown is the BRCAI gene (Miki et al., 1994) which does not have a B-box or coiled-coil domain and is a member of the RING finger superfamily (Freemont. 1993 ).
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screened both oocyte and brain libraries to identify other members of the xnf7 family. After sequencing-15 different cDNA clones, we found two types, one predominantly in the oocyte library and the other predominantly in the brain library. We refer to these two types as the oocyte specific (xnf7-0) and the brain specific (xnff-B) xnf7 cDNAs. Fig. 2A shows a comparison of the amino acids encoded by the xnff-B and xnfi'-0 cDNAs. Within the coding region there are 39 amino acid differences scattered throughout the cDNA. The location of these differences make it unlikely that they are due to posttranscriptional modifications of the RNA such as splicing. At the DNA level x&i'-B and xnf7-0 are 91% identical within the coding region. However, the homology is only 45% in the noncoding regions from which gene specific probes were generated.
In addition to the tripartite zinc finger coiled-coil motif described above xnf7 possesses several other conserved domains such as a cytoplasmic retention domain (CRD, amino acids 52-74), several phosphorylation sites (site 1, amino acid 103, and site 2, amino acids 209, 212, and 218), and an acidic transactivation domain (amino acids 1-128) (Fig. 2B and Li et al., 1994b) . All of these domains play important roles in the function of xnf7 Li and Etkin, 1993; Li et al., 1994a,b) . It is apparent that the majority of differences between the brain and oocyte cDNAs are conservative changes that would not affect the function of any of these domains. However, there is a change from a ser to gly at amino acid 242 that is in the middle of the B-box zinc binding region.
2.2. The xn.-0 and xnj7-B show dijferent temporal but overlapping spatial patterns of expression during development reported that a probe from the complete xnf7 cDNA recognized a 2.6 kB transcript that was detected at high levels in oocytes and fertilized eggs but declined in abundance from fertilization through the gastrula stage. The xnf7 mRNA titer increased at the neurula stage and was detected primarily in the CNS and other dorsal structures of stage 26 embryos by in situ hybridization of histological sections .
We were interested in determining the pattern of expression of the xnfY'-0 and x&'-B cDNAs during development. Gene specific-probes were generated by taking advantage of the differences in nucleic acid sequences in the untranslated leader and trailer regions of the mRNAs. Fig. 3 is a northern blot analysis of the expression of both mRNAs during development from oocyte stages through the late tailbud stages using the gene specific probes. The xnf7-0 probe recognized a 2.6 kB and a minor 2.4 kB transcript. The xnf7-0 mRNA was highly abundant in oocytes and declined in abundance until the blastula stage (stage 8) after which its titer increased reaching a constant level at the tailbud stages and remaining there until stage 40. It was detected at very low levels in adult brain RNA. The xnfl-B probe also recognized a major 2.6 kB and minor 2.4 kB transcript. The xnf7-B mRNA, however, was either absent or detected at very low levels from fertilization through the neurula stage (stage 19) after which its titer also increased, reaching its highest level at stage 40. Xnf7-B was detected in adult brain. Fig. 3 also shows the levels of histone and EFla mRNAs as internal standards from the same RNA samples.
We also examined the spatial pattern of expression of xnf7 mRNAs by performing whole mount in situ hybridization and doing northern blots on RNA isolated from dissected dorsal and ventral regions of embryos. Using the whole xnf7 cDNA as a probe that recognized both x&7-0 and xnf7-B for in situ hybridization, we detected the xnt7 mRNA predominantly in the neural folds with some expression in the somitic mesoderm and notochord at stage 17 ( Fig. 4A) . At the late tailbud stage 26 we detected the xnf7 mRNA distributed throughout the entire dorsal region of the embryo including the neural tube and somites. In addition, it was detected throughout the head region of the embryo (Fig. 4A) . Sections of stage 17 and stage 26 embryos that were hybridized with the xnfl probe confirm the localization to these dorsal structures (Fig. 4B) .
Northern blots of RNA from stage 25 and 45 embryos probed with the whole xnf7 probe showed that the majority of xnf7 mRNAs were indeed localized to the dorsal region of the embryo (Fig. 4C) . The xnf7-0 and xnf7-B gene specific probes did not show any significant differences from the hybridization pattern of the whole xnf7 probe (data not shown). Therefore, we conclude that the spatial pattern of zygotic gene expression of both xnf7-0 and xnf7-B was identical, with mRNAs from both genes reexpressed in the dorsal region of the embryo.
Reexpression of both oocyte and brain forms of xnj7 is affected by ventralizing and dorsalizing agents
UV irradiation of the vegetal region of Xenopus eggs prior to cortical rotation results in ventralized embryos lacking dorsal-anterior axial structures, while treatment with lithium results in dorsalized embryos with large anterior-dorsal structures (Gerhart et al., 1989) . We therefore determined the effect of UV irradiation and lithium treatment on the expression of xnfl. Fig. 5 shows that in embryos treated with UV prior to cortical rotation there was no detectable xnfl mRNA. These embryos ranged from l-3 on the DA1 scale (Kao and Elinson, 1988) . On the other hand, lithium treated embryos showed slightly increased levels of xnf7 expression (Fig. 5 ). These embryos ranged from DA1 7-9. Control embryos that did not undergo either treatment showed intermediate levels comparable to normal embryos. These results in conjunction with the in situ hybridization analysis provides strong (0) clone is 2.44 kB in length compared to 2.4 kB for the brain (B) clone. The full amino acid sequence of the oocyte clone is shown with the amino acid differences between it and the brain clone shown above. The asterisk represents the first stop codon present in both the brain and oocyte cDNAs. The single underlined region represents the CRD; the bracketed region represents the RING and B-box zinc finger domains. B. Diagram of the domain structure of the xnf7 cDNA. CRD, cytoplasmic retention domain; P, phosphorylation sites; NLS, nuclear localization signal; RING finger and B-box zinc finger domains; Coiled-coil domain. 1Org of total RNA isolated from oocytes and different stage X. laevis embryos was separated by electrophoresis and blotted onto Nytran membrane. The northern blot was hybridized with random-prime labeled xnf7 cDNA probes (specific activity 1 X lo9 cpm/,ug) 00. oocytes; different embryonic stages are indicated by the numbers at the top of the figure (Nieuwkoop and Faber, 196'7) . The top panel was from a blot hybridized with a probe produced from the 5' untranslated leader sequence of the oocyte clone. The second panel is the same blot rehybridized with a brain specific probe from the 3' untranslated trailer of the brain clone. The equivalence and integrity of the RNA was monitored by ethidium bromide staining of the gel prior to blotting (not shown) and by rehybridization of the blot with a Xenopus histone H4 and EFl alpha probes.
evidence that the xnf7 mRNA that is expressed at the neurula stage is spatially limited to the CNS.
A transgene containing 62 bp of the oocyte promoter and the CAT reporter was expressed in injected oocytes
We were interested in characterizing the regulatory region involved in the spatial and temporal regulation of either the oocyte or brain xnf7 genes. A 2 kB region of the xnf7-0 gene was recently cloned and sequenced (Gong and Etkin, unpublished) . A computer scan of this region using the Genetic Computer Group (GCG) transcription factor recognition sites program showed the existence of two Spl-like sites at nts -38 and -87, an E2F site at nt -5 I, a USF site at nt -100, and an API site at nt -399 upstream of the transcription start site.
The site of transcription initiation was mapped using both RNase protection and primer extension and was located approximately 216 nt upstream from the translation start site (data not shown). A series of constructs was produced in which varying lengths of the putative xnf7 promoter 5' to the transcription start site were inserted into a vector containing the CAT coding region (Principaud and Spohr, 1991) . All of the inserts had the same 3' end at nt +201. These constructs were injected into the GVs of stage 5 and 6 Xenopus oocytes to identify the basal transcriptional regulatory elements. Fig. 6 shows that there was no CAT expression after injection of the vector alone or the vector containing a 133 bp fragment of the xnf7 promoter lacking the transcription initiation site (xnflA+ 68). XnflA-62 and xnflA-121 gave the greatest levels of CAT activity in injected oocytes, while xnflA-421 and xnf7A-1516 gave minimal activity (Fig. 6A,B) .
The elements for proper temporal and spatial expression of xn. are contained within 62 bp of the promoter
To determine the location of elements required for the proper temporal and spatial expression of the xnfl-0 gene during development we injected the xnf7 constructs into fertilized eggs and assayed for CAT activity during development.
Fig . 7A ,B shows that in embryos, unlike oocytes, the most active construct was xnflA-421, while the xnf7A-62 was moderately active and xnffh-121 showed low levels of activity. The xnflA-1516 was not active in injected oocytes or embryos. Temporally, the injected xnf7A-421 plasmid was not active prior to the MBT which is consistent with data from other experiments examining the expression of injected genes ( Fig.  7C ) (Bendig and Williams, 1983; Etkin and DiBerardino, 1983; Etkin et al., 1984; Etkin and Balcells, 1985; Shiokawa et al., 1989) .
We examined the spatial pattern of expression of both the xnflA-62 and xnf7A-421 constructs by dissecting injected embryos at the early tailbud stages into dorsal and ventral regions and assaying for CAT activity and by whole mount in situ hybridization using a CAT sense (S) and antisense (AS) probes. Fig. 7C shows that both constructs were expressed predominantly in the dorsal region of dissected embryos, although maximal levels of expression were obtained with the xnff A-421 construct.
Analysis by whole mount in situ hybridization showed that the expression of the transgene at stages 24 and 33 was limited to patches of cells primarily in the dorsal region of the embryo in a pattern that was almost identical to that of the endogenous xnff-0 and x&7-B transcripts (Fig, 8A) . The patchy appearance of the transcripts is due to the mosaic distribution and/or expression of the injected DNA. Control in situ analysis using the sense strand showed no hybridization confirming that the signal detected was from the RNA expressed from the injected transgene. A whole mount in situ analysis of an embryo that was injected into one of the two blastomeres after first cleavage showed expression of the CAT reporter in the dorsal region of one half of the embryo (Fig. 8B) . These results are consistent with the expression of transgene in the dissected embryos ( Fig. 7C) and clearly indicate that the information for the proper temporal and spatial expression of the xnf7-0 gene at maximal levels is within 421 bp 5' of the transcription start site; however proper spatial expression, albeit at lower levels, also was obtained with as little as 62 bp of the promoter. Interestingly, the xnf7A-121 clone although active in oocytes was inactive in embryos suggesting the presence of a developmentally specific inhibitor or silencer element within this region.
The dorsal pattern of expression of the injected transgene was observed in 50% of the injected embryos (26/52); however, in the other embryos there was either no expression or aberrant expression in sites other than the dorsal region. The region specific pattern of expression of the xnf;r promoter transgene was in contrast to the pattern of expression of reporter constructs driven by the histone H2b promoter that were expressed in patches throughout the embryo (data not shown; Leibham et al., 1994) .
Discussion
We have cloned two different cDNAs coding for xnf7 transcripts. One of these transcripts, xnff-0, was expressed at all stages of early development but at very low levels in adult brain. The other, xn~-B, was expressed at low levels prior to the gastrula stage but was activated at the late gastrula stage. Both forms of the transcripts were expressed predominantly in the dorsal region of the embryo from the neurula stage onward; however, xnf7-0 was not detectable in adult brain. Neither form of xnf7 was expressed in ventralized embryos derived from eggs treated with UV irradiation to inhibit cortical rotation; the titer of xnf7 was increased in embryos that were dorsalized by lithium treatment. This provides strong evidence for a spatially restricted pattern of expression of xnf7 and dependence of its expression on the interactions that occur during mesoderm induction. In addition, we have demonstrated that the information necessary for the proper spatial and temporal expression of the xnf7-0 gene is located within the first 62 bp of the 5' promoter region.
The tripartite RING finger and B-box zinc binding domains and the coiled coil domains of xnf7 are conserved among a large family of genes called the B-box zinc finger family Reddy et al., 1992; Freemont, 1993; Lovering et al., 1993; Borden et al., 1994) . In addition to this tripartite domain we have identified, within xnfl, an acidic NH2 terminal transactivation domain (aa l-152) and a 22 amino acid domain, the CRD, involved in cytoplasmic retention (Li et al., 1994a,b) . The majority of amino acid differences between xnf;r-0 and xnf7-B do not fall within these domains and those that do appear to be conservative in nature. One of the amino acid changes (ser/gly at amino acid 242) does have the potential to alter the structure within the B-box zinc binding domain. Borden et al. (1993) showed that the B-box binds zinc and that this interaction is crucial to the formation of a secondary structure. We have evidence that the B-box zinc binding domain functions in homodimerization (Cao and Etkin, in preparation). It is conceivable that the change from serine to glycine in the oocyte clone may influence the spatial orientation of Cys 25 and thus affect the ability of xnt7 to dimerize. This determination will have to await the results of the high resolution structural analysis that is currently underway.
Due to the pseudo-tetraploid ancestry in Xenopus, it is not unusual to find two copies of a gene, each of which has evolved a unique pattern of expression (Bisbee et al., 1977) . Besides xnf7, several other examples include the c-myc genes (Vriz et al., 1989) , and the myogenic factor XMyoD (Hopwood et al., 1989; Scales et al., 1990) . In neither of these examples could a case be made for differences in the function of these proteins, suggesting that the duplication is likely a peculiarity of Xenopus ancestry. It is possible that the xnf7-0 and xnf;r-B represent copies of the same gene instead of two separate genes. We favor the interpretation that they are two separate genes based on their different patterns of expression .
Xnf7 functions during early development prior to or shortly after the MBT in the establishment of dorsalventral patterning of the embryo (Shou et al., submitted) , and yet it is expressed at the neurula stage in a regionspecific manner. This dual pattern of expression is not uncommon. For example, in Drosophila the exuperantia (Hazelrigg et al., 1990) and vasa (Hay et al., 1988) genes are involved in embryonic patterning but are later expressed during spermatogenesis.
Also in Drosophila there is a large group of maternally expressed patterning genes that function later in development in the differentiation of the nervous system (see Goodman and Doe, 1993) . The reexpression of both the xnf7-0 and xnff-B at the neurula stage in a spatially restricted pattern is intriguing and leaves us with the question of the function that xnf7 plays during later stages of embryogenesis and in the adult when it is predominantly expressed in the CNS.
To study the promoter elements involved in the transcription of the xnf7 gene in Xenopus oocytes and embryos, we compared the activity of chimeric genes in which the CAT-coding sequence was under the control of xnfl promoter elements. The elements that controlled the basal level of transcription were contained within the region 62 bps upstream of the transcriptional initiation site.
Preliminary mapping of the putative binding regions of the promoter by DNase footprint assays with oocyte extracts showed that the E2F and Spl-like binding sites, located between -68 and -37 and a second Spl-like site located at position -92 to -84, were protected (Gong and Etkin, unpublished observations). The fact that 2 Spl-like and an E2F site were bound by factors in the oocyte extract was not surprising since these binding sites have been implicated in the basal regulation of many other TATA-less promoters (Azizkhan et al., 1993) .
We demonstrated that, temporally, the xnf7lCAT fusion genes were expressed after the MBT which is when the endogenous xnfl gene is reactivated. A number of other cloned Xenopus genes were also regulated in the correct temporal manner when introduced into embryos. These include the Xenopus rRNA genes (Busby and Reeder, 1983) , GS17 (Krieg and Melton, 1985) , cardiac actin gene (Mohun et al., 1986; Wilson et al., 1986) and keratin gene (Jonas et al., 1989) . Furthermore, Krieg and Melton (1987) were able to define a 74-base enhancer responsible for activating transcription of the GS17 gene at the MBT.
Currently, there are several examples of correct tissuespecific expression of injected genes which include a-actin (Mohun et al., 1986; Wilson et al., 1986) , expressed only in muscle, XK81Al (Jonas et al., 1989) a keratin expressed only in epidermis, and the XMyoDa (Leibham et al., 1994) expressed in a somite-specific manner. . Expression of x&7-CAT transgene in injected oocytes. Constructs (1 ng) containing various lengths of the xnfl-0 promoter were injected into the GVs of stage 5 and 6 Xenopus oocytes. Injected oocytes were incubated for 24 h, homogenized and the extracts analyzed for CAT activity. A. CAT assay assessing the ability of the various length xnff-0 promoter segments to induce reporter gene activity. Lane 1, extracts from uninjected oocytes; Lane 2, oocytes injected with the CAT vector alone with no xnf7 insert; Lane 3, extract from oocytes injected with a construct containing the c-myc promoter as a positive control (Principaud and Spohr, 1991) ; Lane 4, extract from oocytes injected with the xnffA+68 construct lacking the transcription initiation site; Lane 5, extract from.oocytes injected with the xnffA-62 construct; Lane 6, extract from oocytes injected with the xnffA-121 construct; Lane 7, extract from oocytes injected with the xnfi'A-421 construct: extract from oocytes injected with the xnt7A-1516 construct. B. Diagram of constructs used and quantitation of the CAT activity in injected oocytes. Arrow is located at the transcriptional start site.
The region of the xnj7 promoter that conferred spatialtally regulated silencer or repressor region within the respecificity was within 62 bps upstream of the transcripgion -62 to -121. There is a consensus USF binding site tional initiation site. This region possesses Spl-like and at 100; however, there is no precedent for this to act as a E2F consensus sites; however, it is not clear how these repressor sequence. Additionally, the xnflA-421 confunction to produce the proper spatial pattern of expresstruct was also expressed in the proper temporal and spasion. Also, the shorter xnf7A-121 gave low levels of tial manner but at a higher level than the xnf7A-62 pro-CAT activity in the embryo, while being extremely active moter construct. Two interesting putative binding sites are in the oocyte suggesting that there may be a developmenpresent from -121 to -421, one the API binding site and 
Experimental procedures
cDNA isolation and sequence analysis
The original xnf7 cDNA was obtained by screening a cDNA expression library prepared from X. Zaevis brain poly(A)+ RNA in lambda gtll (constructed by Dr. K. Richter) with the 37-IA9 monoclonal antibody that recognizes the xnf7 protein (Dreyer et al., 1981; . We used this cDNA to screen both the brain library and an oocyte lambda gtl0 cDNA library to obtain new xnf7-like cDNAs. Inserts from the isolated recombinant clones were characterized and subcloned into pbluescribe (Stratagene), and the complete nucleotide sequence of both strands of the clones was determined using dideoxy sequencing with Sequenase according to manufacturer's specifications (United States Biochemical).
Construction offusion genes
In order to make the xnf7 promoter constructs, an oligo S'CTCCTCGTCACGGGCACCCGA3' located at nt +201 in the xnf7 cDNA was used in a polymerase chain reaction with the T7 promoter, located within the vector itself. The templates used were that of the different xnf7 nested deletion products containing different lengths of the putative promoter region. The products obtained from the PCR reaction were filled in using Klenow enzyme to create blunt ends and ligated to a CAT vector. This vector originated from pUC18, and contained the coding region of the CAT gene as well as the small t intron and polyadenylation signals from SV40. In addition, it was modified to include upstream of the promoter insertion site a DNA fragment containing the termination sites of Pol II and III (Principaud and Spohr, 1991) to avoid interference in the transcription of the insert by cryptic promoters located in the plasmid sequence. A construct containing mycl promoter sequences extending +46 to -189 was used as positive control (Modak et al., 1993) .
Oocyte and embryo injection
Female frogs were anesthetized in 3-aminobenzoic acid ethyl ester (Sigma). A section of the ovaries was surgically removed, and stage V and Vl oocytes were manually defolliculated and maintained in MBS. Oocytes were injected with 250 pg (0.1 pg/pl) of DNA (Etkin and Maxson, 1980) . Eggs fertilized by artificial insemination were injected within 1 h according to Etkin et al. (1984) with 100-150 pg of DNA in a volume of 5-10 nl. The CAT assays were done according to Etkin and Balcells (1985) and Gorman et al. (1982) . Quantitation was performed on the thin layer chromotagrams, using a Molecular Dynamics Phosphorimager.
RNA isolation, northern hybridization analysis
Total RNA from oocytes and different staged embryos or various adult tissues was isolated and separated on formaldehyde-agarose gels and blotted onto genescreen plus membrane. In some cases embryos were manually dissected into dorsal and ventral regions and RNA was extracted from pools of 20-30 pieces. The blots were hybridized with random-prime labeled probe prepared from the whole xnfl cDNA insert or regions of the 5' or 3' untranslated leader or trailer sequences. Some of the blots were rehybridized with a histone H4 and EFla DNA probes (gifts from M. Perry and P. Kreig, respectively) to assess the loading equivalencies.
The size of the xnff mRNA was determined by comparison with RNA molecular weight markers (Boehringer Mannheim).
UV irradiation of Xenopus eggs and treatment with lithium
Fertilized eggs were dejellied in 1% cysteine in 0.1 X Barth's solution (pH 7.8). The embryos were placed on a quartz glass slide 30 min after fertilization and UV irradiated in the vegetal hemisphere. Completely ventralized embryos (Kao and Elinson, 1988) were used for analysis of xnf7 transcripts. Dorsalized embryos were produced by treatment of 64 cell stage embryos for 1 h with 0.1 M Li Cl in 0.1 X Barth's solution.
Probes for in situ hybridization
Complementary RNA probes were synthesized from linearized plasmid templates in the presence of digoxigenin-1 l-UTP (BMB). For sense probe the xnfl-8 cDNA clone was linearized with EcoRV and transcribed with Sp6 RNA polymerase. Antisense probes were prepared by linearizing with Pstl and transcribing with T7 polymerase. The size of transcripts was reduced by 40 mM sodium bicarbonate and 60 mM sodium carbonate hydrolysis at 60°C for 30 min. RNA was precipitated with 4M LiCI and ethanol and resuspended in hybridization buffer. Probes for whole mount in situ hybridization of CAT gene expression were prepared similarly. Whole mount in situ hybridizations were done in 6 well and 24 well culture plates with shaking on a rotating platform according to Harland (1991) and Kloc and Etkin (1995) .
